These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34953925)

  • 1. Characterizing primary care for patients with major depressive disorder using electronic health records of a US-based healthcare provider.
    Larson S; Nemoianu A; Lawrence DF; Troup MA; Gionfriddo MR; Pousti B; Sun H; Riaz F; Wagner ES; Chrones L; Touya M
    J Affect Disord; 2022 Mar; 300():377-384. PubMed ID: 34953925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmet need in major depressive disorder and acute suicidal ideation or behavior: findings from a longitudinal electronic health record data analysis.
    Neslusan C; Chen YW; Sharma M; Voelker J
    J Med Econ; 2023; 26(1):1-10. PubMed ID: 36205512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States.
    Pizzicato LN; Xie RZ; Yang Y; Grabner M; Chapman RH
    J Manag Care Spec Pharm; 2023 Jun; 29(6):614-625. PubMed ID: 37276037
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis.
    Gauthier G; Guérin A; Zhdanava M; Jacobson W; Nomikos G; Merikle E; François C; Perez V
    BMC Psychiatry; 2017 Jun; 17(1):222. PubMed ID: 28629442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Relationship Between Depression Symptom Severity and Health Care Costs for Patients With Treatment-Resistant Depression.
    Lynch FL; Dickerson JF; O'Keeffe-Rosetti M; Chow W; Pesa J
    J Clin Psychiatry; 2022 Feb; 83(2):. PubMed ID: 35120286
    [No Abstract]   [Full Text] [Related]  

  • 6. Comorbidity and healthcare utilization in patients with treatment resistant depression: A large-scale retrospective cohort analysis using electronic health records.
    Adekkanattu P; Olfson M; Susser LC; Patra B; Vekaria V; Coombes BJ; Lepow L; Fennessy B; Charney A; Ryu E; Miller KD; Pan L; Yangchen T; Talati A; Wickramaratne P; Weissman M; Mann J; Biernacka JM; Pathak J
    J Affect Disord; 2023 Mar; 324():102-113. PubMed ID: 36529406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.
    Amos TB; Tandon N; Lefebvre P; Pilon D; Kamstra RL; Pivneva I; Greenberg PE
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?
    Pilon D; Sheehan JJ; Szukis H; Morrison L; Zhdanava M; Lefebvre P; Joshi K
    J Affect Disord; 2019 Aug; 255():50-59. PubMed ID: 31128505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.
    Valuck RJ; Libby AM; Sills MR; Giese AA; Allen RR
    CNS Drugs; 2004; 18(15):1119-32. PubMed ID: 15581382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depression.
    Pilon D; Szukis H; Singer D; Morrison L; Sheehan JJ; Lefebvre P
    Curr Med Res Opin; 2020 May; 36(5):865-874. PubMed ID: 31985319
    [No Abstract]   [Full Text] [Related]  

  • 11. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
    Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
    PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization.
    Armstrong AW; Foster SA; Comer BS; Lin CY; Malatestinic W; Burge R; Goldblum O
    BMC Dermatol; 2018 Jun; 18(1):4. PubMed ID: 29954363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden associated with inadequate antidepressant medication management among patients with depression and known cardiovascular diseases: insights from a United States-based retrospective claims database analysis.
    Bangalore S; Shah R; Gao X; Pappadopulos E; Deshpande CG; Shelbaya A; Prieto R; Stephens J; Chambers R; Schepman P; McIntyre RS
    J Med Econ; 2020 Mar; 23(3):262-270. PubMed ID: 31665949
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder.
    Seetasith A; Greene M; Hartry A; Burudpakdee C
    J Med Econ; 2018 Sep; 21(9):888-901. PubMed ID: 29862860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
    Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
    Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare resource utilization in patients with treatment-resistant depression-A Danish national registry study.
    Jensen KJ; Gronemann FH; Ankarfeldt MZ; Jimenez-Solem E; Alulis S; Riise J; Bødker N; Osler M; Petersen J
    PLoS One; 2022; 17(9):e0275299. PubMed ID: 36166443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and Impact of Electronic Health Records-Defined Depression Phenotypes in Spine Surgery.
    Boakye M; Sharma M; Adams S; Chandler T; Wang D; Ugiliweneza B; Drazin D
    Neurosurgery; 2021 Jun; 89(1):E19-E32. PubMed ID: 33862621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People's Republic of China.
    Zhang L; Chen Y; Yue L; Liu Q; Montgomery W; Zhi L; Wang W
    Neuropsychiatr Dis Treat; 2016; 12():941-9. PubMed ID: 27143895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of treatment-resistant depression among veterans in the United States.
    Szukis H; Joshi K; Huang A; Amos TB; Wang L; Benson CJ
    Curr Med Res Opin; 2021 Aug; 37(8):1393-1401. PubMed ID: 33879005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of treatment-related discussions on healthcare resource use and costs among patients with severe mental illness.
    Forma F; Koep E; White J; Belland A; Waters H; Martin C
    Curr Med Res Opin; 2021 Oct; 37(10):1799-1809. PubMed ID: 34139902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.